ProShares Russell 2000 High Income ETF Rating $42.59 -0.14 (-0.33%) Closing price 11/13/2026 04:10 PM EasternExtended Trading$42.52 -0.07 (-0.15%) As of 11/13/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest ProShares Russell 2000 High Income ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ITWO Aggregate RatingModerate Buy 2.78Holdings in ITWO have an aggregate rating of Moderate Buy based on 325 analyst ratings issued in the past year covering 23 companies (6.7% of the portfolio).ITWO Aggregate Price Target$42.59High Prediction$42.59Average Prediction$42.59Low Prediction$42.59Holdings in ITWO have an aggregate price target of $42.59 and a range of $42.59 to $42.59 covering 23 companies (6.7% of the portfolio).ITWO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Russell 2000 High Income ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 ITWO Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings0.42%GKOSGlaukos$245.60-0.2%Moderate Buy$216.71 -11.8%162.6542 of 5 stars0.37%BTSGBrightSpring Health Services$71.21-0.3%Buy$77.81 9.3%193.6699 of 5 starsPositive News0.33%MOG.AMoog$339.42-1.0%Moderate Buy$446.25 31.5%53.8947 of 5 stars0.32%UMBFUMB Financial$133.86+0.3%Moderate Buy$161.64 20.8%164.9686 of 5 stars0.31%VSATViasat$67.72-4.9%Moderate Buy$98.56 45.5%113.0663 of 5 starsGap Down0.30%FROGJFrog$113.60+2.7%Moderate Buy$113.10 -0.4%231.7492 of 5 starsAnalyst Forecast0.29%JXNJackson Financial$138.94+0.2%Hold$134.80 -3.0%62.2947 of 5 starsGap Up0.29%TWSTTwist Bioscience$111.60-2.3%Hold$141.00 26.3%123.0094 of 5 starsTrending NewsEarnings ReportAnalyst ForecastGap Down0.29%RHPRyman Hospitality Properties$135.20-1.0%Moderate Buy$136.67 1.1%143.2078 of 5 starsAnalyst Forecast0.28%SMSM Energy$32.71-0.2%Moderate Buy$39.82 21.8%184.9183 of 5 starsPositive News0.28%TGTXTG Therapeutics$64.51-0.1%Moderate Buy$63.00 -2.3%91.8247 of 5 starsEarnings ReportAnalyst Upgrade0.28%CTRECareTrust REIT$38.06-0.2%Moderate Buy$43.71 14.9%154.7466 of 5 starsNews CoverageAnalyst ForecastAnalyst Revision0.28%EATBrinker International$198.61+0.5%Moderate Buy$249.80 25.8%234.8377 of 5 starsTrending NewsAnalyst Revision0.28%ONBOld National Bancorp$25.05+0.4%Moderate Buy$29.57 18.0%144.702 of 5 starsDividend Announcement0.27%PCVXVaxcyte$63.37-2.0%Moderate Buy$110.50 74.4%93.1379 of 5 starsNews CoverageInsider Trade0.27%PTGXProtagonist Therapeutics$130.95-2.6%Buy$166.67 27.3%173.5626 of 5 starsPositive NewsAnalyst Revision0.27%CYTKCytokinetics$56.13-0.1%Moderate Buy$106.67 90.0%213.1604 of 5 starsInsider TradeOptions Volume0.27%HQYHealthEquity$103.46+0.4%Moderate Buy$113.53 9.7%133.8171 of 5 starsPositive News0.26%IDCCInterDigital$288.62-2.3%Moderate Buy$425.00 47.3%43.1169 of 5 stars0.25%KRYSKrystal Biotech$305.23-0.1%Moderate Buy$375.00 22.9%143.4348 of 5 stars0.25%KYMRKymera Therapeutics$127.57+0.3%Moderate Buy$139.16 9.1%271.9836 of 5 stars0.25%FCFSFirstCash$184.70+1.7%Moderate Buy$247.50 34.0%64.5077 of 5 starsPositive News0.25%OSCROscar Health$31.15-2.5%Hold$34.60 11.1%134.3255 of 5 stars This page (BATS:ITWO) was last updated on 11/15/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredSHOCKING! Prediction caught on cameraNewly released footage shows James Altucher pulling a document out of a briefcase on camera. It is a document ...Paradigm Press | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Russell 2000 High Income ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Russell 2000 High Income ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.